Logo Logo
Hilfe
Hilfe
Switch Language to English

Fischer, T.; Sattler, G. und Gauglitz, G. (2016): Lidocainhaltiger Hyaluronfiller auf CPM®-Basis zur Lippenaugmentation. Erfahrungsberichte aus der Praxis. In: Hautarzt, Bd. 67, Nr. 6: S. 472-478

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Lip augmentation with hyaluronic acid fillers is an established procedure. As monophasic polydensified hyaluronic acid products with variable density CPM-HAL1 (BeloteroA (R) Balance Lidocaine) and CPM-HAL2 (BeloteroA (R) Intense Lidocaine) are qualified for beautification and particularly natural-looking rejuvenation, respectively. Assessment of handling and outcome of lip augmentation using the lidocaine-containing hyaluronic acid fillers CPM-HAL1 and CPM-HAL2. Data from patients who received lip augmentation by means of bautification and/or rejuvenation using CPM-HAL1 and/or CPM-HAL2 were documented. Observation period was 4 months, with assessment of natural outcome, evenness, handling, fluidity, distribution, malleability, tolerability, as well as patient satisfaction and pain. In total, 146 patients from 21 German centres participated. Physicians rated natural outcome and evenness as good or very good for > 95 % of patients. Handling, fluidity, distribution and malleability were assessed for both fillers as good or very good in > 91 % of patients. At every evaluation point, more than 93 % of patients were very or very much satisfied with the product. A total of 125 patients (85.6 %) experienced transient injection-related side effects. Pain intensity during the procedure was mild (2.72 +/- 1.72 on the 0-10 pain assessment scale) and abated markedly within 30 min (0.42 +/- 0.57). Lip augmentation with hyaluronic acid fillers produced a long-term cosmetic result. Due to the lidocaine content, procedural pain was low and transient. Accordingly, a high degree of patient satisfaction was achieved that was maintained throughout the observation period.

Dokument bearbeiten Dokument bearbeiten